West Pharmaceutical Services
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. West Pharmaceutical Services's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2% to $2,949,800,000. The net income raised on $593,400,000 and profit margin reached 20%. Total operating expenses were $454,000,000.
Profit Margin
| 2014 | 1.42B | 127.1M | 8.94% |
|---|---|---|---|
| 2015 | 1.39B | 95.6M | 6.83% |
| 2016 | 1.50B | 143.6M | 9.52% |
| 2017 | 1.59B | 150.7M | 9.42% |
| 2018 | 1.71B | 206.9M | 12.05% |
| 2019 | 1.83B | 241.7M | 13.14% |
| 2020 | 2.14B | 346.2M | 16.13% |
| 2021 | 2.83B | 661.8M | 23.37% |
| 2022 | 2.88B | 585.9M | 20.3% |
| 2023 | 2.94B | 593.4M | 20.12% |
WST Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.94B | 2.88B | 2.83B | 2.14B | 1.83B | 1.71B | 1.59B | 1.50B | 1.39B | 1.42B |
Cost of revenue | 1.82B | 1.75B | 1.65B | 1.37B | 1.23B | 1.17B | 1.08B | 1.00B | 944M | 973.6M |
Gross profit | 1.12B | 1.13B | 1.17B | 767.8M | 605.7M | 545.4M | 512.6M | 501.1M | 455.8M | 447.8M |
Operating exp. | ||||||||||
Research and development | 68.4M | 58.5M | 52.8M | 46.9M | 38.9M | 40.3M | 39.1M | 36.8M | 34.1M | 37.3M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 454M | 402.2M | 423.5M | 360.9M | 311.6M | 303.2M | 281.7M | 276.6M | 267.1M | 266M |
Operating income | 676M | 734M | 752.3M | 406.9M | 296.6M | 240.3M | 228.9M | 196.8M | 128.6M | 182M |
Other income (expenses), net | 22M | -54.1M | -3.4M | -5.6M | -4.8M | 4.8M | -3.4M | -27.7M | -12.5M | -13M |
Income before tax | 698M | 679.9M | 748.9M | 401.3M | 291.8M | 240.7M | 222.4M | 189.8M | 116.1M | 169M |
Income tax expense | 122.3M | 114.7M | 107.2M | 72.5M | 59M | 41.4M | 80.9M | 54.4M | 26.3M | 47.2M |
Net income | 593.4M | 585.9M | 661.8M | 346.2M | 241.7M | 206.9M | 150.7M | 143.6M | 95.6M | 127.1M |
Earnings per share | ||||||||||
Basic EPS | 7.99 | 7.88 | 8.9 | 4.68 | 3.27 | 2.8 | 2.04 | 1.96 | 1.33 | 1.79 |
Diluted EPS | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 | 1.3 | 1.75 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |